|
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov. |
NIDA-CTN-0105
Division
HEAL Study
Investigator(s)
Title
Integrating Pharmacy-Based Prevention and Treatment of Opioid and Other Substance Use Disorders: A Survey of Pharmacists and Stakeholders
Short Description
The overall goal of this study is to investigate community pharmacists’ knowledge of, attitudes about, and intention to provide patient care and services for Screening for substance use/misuse and Referral to Treatment (SRT) for substance use disorders (SUDs) and Medication treatment for Opioid Use Disorders (MOUD).
Release Date
May 23, 2025
Description
Study aims are to:
Aim 1: Conduct a survey of licensed community pharmacists to study their knowledge of, attitudes about, and intention to provide patient care and services for SRT and MOUD; and
Aim 2: Conduct a qualitative interview of a sample of up to 50 survey participants (range: 20 to 50 participants) from Aim 1 to further assess survey participants’ interest in implementing preventive care services for SUDs and medication therapy management for patients with opioid use disorder (OUD) in their practice.
Together, the results will inform pharmacy-based study designs and future directions for the NIDA National Drug Abuse Treatment Clinical Trials Network (CTN) studies as well as training and educational needs for community pharmacists.
Keywords
Accessibility Notice
Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.